NOXA‐mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin‐treated human acute myeloid leukemia cells
Authors:
- 13 May 2021
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 236 (11) , 7356-7375
Abstract
Daunorubicin (DNR) is used clinically to treat acute myeloid leukemia (AML), while the signaling pathways associated with its cytotoxicity are not fully elucidated. Thus, we investigated the DNR‐induced death pathway in the human AML cell lines U937 and HL‐60. DNR‐induced apoptosis in U937 cells accompanied by downregulation of MCL1 and BCL2L1, upregulation of Phorbol‐12‐myristate‐13‐acetate‐induced protein 1 (NOXA), and mitochondrial depolarization. DNR induced NOX4‐mediated reactive reactive oxygen species (ROS) production, which in turn inactivated Akt and simultaneously activated p38 mitogen‐activated protein kinase (MAPK). Activated p38 MAPK and inactivated Akt coordinately increased GSK3β‐mediated cAMP response element‐binding protein (CREB) phosphorylation, which promoted NOXA transcription. NOXA upregulation critically increased the proteasomal degradation of MCL1 and BCL2L1. The same pathway was also responsible for the DNR‐induced death of HL‐60 cells. Restoration of MCL1 or BCL2L1 expression alleviated DNR‐induced mitochondrial depolarization and cell death. Furthermore, ABT‐199 (a BCL2 inhibitor) synergistically enhanced the cytotoxicity of DNR in AML cell lines. Notably, DNR‐induced DNA damage was not related to NOXA‐mediated degradation of MCL1 and BCL2L1. Collectively, these results indicate that the upregulation of NOXA expression through the NOX4‐ROS‐p38 MAPK‐GSK3β‐CREB axis results in the degradation of MCL1 and BCL2L1 in DNR‐treated U937 and HL‐60 cells. This signaling pathway may provide insights into the mechanism underlying DNR‐triggered apoptosis in AML cells.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST108‐2320‐B110‐001‐MY2)
This publication has 54 references indexed in Scilit:
- Elevated H2AX Phosphorylation Observed with kINPen Plasma Treatment Is Not Caused by ROS-Mediated DNA Damage but Is the Consequence of ApoptosisOxidative Medicine and Cellular Longevity, 2019
- The role of TP53 in acute myeloid leukemia: Challenges and opportunitiesGenes, Chromosomes and Cancer, 2019
- Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemiaBMC Cancer, 2019
- Targeting apoptosis in acute myeloid leukaemiaBritish Journal of Cancer, 2017
- Gene and protein analysis reveals that p53 pathway is functionally inactivated in cytogenetically normal Acute Myeloid Leukemia and Acute Promyelocytic LeukemiaBMC Medical Genomics, 2017
- Impact of loss of BH3-only proteins on the development and treatment of MLL-fusion gene-driven AML in miceCell Death & Disease, 2016
- Targeting BCL2 for the Treatment of Lymphoid MalignanciesSeminars in Hematology, 2014
- Intercalation of antitumor drug doxorubicin and its analogue by DNA duplex: Structural features and biological implicationsInternational Journal of Biological Macromolecules, 2014
- Beneficial effects of angiotensin II receptor blocker, olmesartan, in limiting the cardiotoxic effect of daunorubicin in ratsFree Radical Research, 2010
- Chronic Lithium Salt Treatment Reduces CRE/CREB-Directed Gene Transcription and Reverses Its Upregulation by Chronic Psychosocial Stress in Transgenic Reporter Gene MiceNeuropsychopharmacology, 2007